Preclinical Efficacy & Mechanistic Studies for
Nutraceuticals
At AAL Biosciences, we transform nutraceutical innovation into measurable biological proof. Our preclinical platforms evaluate how functional ingredients influence metabolism, immunity, cognition, inflammation, and gut health, uncovering both the efficacy and the mechanisms behind their benefits.
From in-vivo models to cellular assays, PK profiling, and biomarker analytics, we deliver robust data that support product claims, regulatory submissions, and formulation optimisation.
Necessity of Preclinical Efficacy & Mechanistic Studies for Nutraceuticals
These studies validate nutraceutical performance, reveal biological mechanisms, and ensure products deliver real functional benefits.
Substantiates Functional Claims
Provides scientific evidence for antioxidant, metabolic, cognitive, and gut health benefits.
Reveals Mechanism of Action
Explains how ingredients work through biomarker shifts, molecular pathways, and tissue-level changes.
Supports Dose Selection & Bioavailability
Defines effective doses and tracks absorption, metabolism, and tissue distribution.
Ensures Safety & Biological Compatibility
Screens cytotoxicity, organ effects, and nutrient interactions before clinical use.
Strengthens Regulatory & Market Readiness
Delivers defensible data required for label claims, approvals, and global credibility.
Optimises Formulation Performance
Identifies synergistic effects, nutrient uptake efficiency, and stability under physiological conditions.
Area of Expertise
